Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 20 (2004), Issue 6, Pages 289-294
http://dx.doi.org/10.1155/2004/715745

The Matrix Metalloproteinase-3 (MMP-3) 5A/6A Promoter Polymorphism Is Not Associated with Ischaemic Heart Disease: Analysis Employing a Family Based Approach

Paul G. McGlinchey,1 Mark S. Spence,1 Chris C. Patterson,2 Adrian R. Allen,3 Gillian Murphy,1 Damian Fogarty,3 Alun Evans,2 and Pascal P. McKeown1,3

1Regional Medical Cardiology Centre, Royal Victoria Hospital, Grosvenor Road, Belfast, BT12 6BA, UK
2Department of Epidemiology and Public Health, Queen's University Belfast, Mulhouse Building, Grosvenor Road, Belfast, Northern Ireland BT12 6BJ, UK
3Department of Medicine, Queen's University Belfast, Institute of Clinical Science, Grosvenor Road, Belfast, Northern Ireland BT12 6BJ, UK

Received 18 January 2005; Accepted 18 January 2005

Copyright © 2004 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Paul G. McGlinchey, Mark S. Spence, Chris C. Patterson, et al., “The Matrix Metalloproteinase-3 (MMP-3) 5A/6A Promoter Polymorphism Is Not Associated with Ischaemic Heart Disease: Analysis Employing a Family Based Approach,” Disease Markers, vol. 20, no. 6, pp. 289-294, 2004. doi:10.1155/2004/715745